MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$23,328K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Payment of a&e term loan facilit...
Amortization of intangibles
Other current liabilities
Others
Negative Cash Flow Breakdown
Deferred revenue
Depreciation, amortization and p...
Accounts payable and accrued exp...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total adjusted ebitda
207,046
130,575
135,867
286,406
Interest expense (income), net
-45,770
-45,154
-47,358
-55,940
Income tax benefit (provision)
10,652
-2,471
-4,950
-21,060
Depreciation, amortization and product development amortization
83,476
85,571
95,671
92,822
Restructuring and cost savings implementation charges
3,746
2,402
3,894
1,774
Advisory fees
0
0
0
625
Impairment charge
-
39,000
-
-
Purchase accounting
-
0
-
-
Transaction and integration costs
0
373
548
170
Stock-based compensation
3,884
1,986
661
31,076
Gain (loss) on extinguishment of debt
-
-1,222
-8,183
-16,361
Other
1,658
7,605
4,701
3,414
Net income (loss)
57,860
-50,267
-20,199
105,284
Amortization of inventory purchase accounting adjustments
-
0
-
-
Depreciation (including amortization of technology costs)
16,348
19,767
27,308
17,723
Amortization of intangibles
53,500
54,460
55,417
56,385
Amortization of product development costs
13,628
11,344
12,946
18,714
Amortization of capitalized contract costs-Royalty
38,039
8,532
9,397
23,588
Amortization of capitalized contract costs-Commission Costs
7,655
6,466
3,350
5,198
Stock-based compensation
3,884
1,986
661
31,076
Credit losses on accounts receivable
-1,251
2,838
-765
2,522
Unrealized (gain) loss on interest rate cap
-
0
0
0
Inventory obsolescence
3,958
886
141
4,673
Deferred income taxes
255
-1,900
-97
78
Amortization of debt discount
3,166
3,053
3,106
3,489
Amortization of deferred financing costs
1,222
1,199
1,210
1,281
(gain) loss on extinguishment of debt
-
-1,222
-8,183
-16,361
Gain on disposition
-
0
-
-
Impairment charge
-
39,000
-
-
Accounts receivable
18,041
123,535
-425,003
219,081
Inventories
-7,864
26,335
36,658
-22,982
Prepaid and other current assets
16,360
35,152
-6,280
70,922
Accounts payable and accrued expenses
-63,566
4,003
14,366
51,935
Deferred revenue
-149,389
-25,138
-217,110
263,627
Other current liabilities
42,342
-42,069
11,066
-65,422
Other changes in operating assets and liabilities, net
513
-3,516
-5,361
4,508
Cash provided by (used for) operating activities
601
-146,124
308,966
264,983
Product development expenditures
34,360
42,321
27,604
26,288
Capital expenditures
23,929
23,823
23,561
21,195
Proceeds from disposition
-
0
-
-
Acquisition of essaypop
-
0
-
-
Cash provided by (used for) investing activities
-58,289
-66,144
-51,165
-47,483
Payment of a&e term loan facility
-388,990
-
-
388,991
Borrowings on 2024 secured notes
-
0
0
0
Borrowings on abl revolving credit facility
-
0
-
-
Payment of term loan facility and secured notes-AECash Flow Credit Facilities AETerm Loan Facility
-
10,000
595,575
-
Payment of term loan facility and secured notes-Term Loan Facility
-
0
0
-
Payment of abl revolving credit facility
-
0
-
-
Repurchase of 2022 unsecured notes
-
39,895
-
-
Payment of deferred financing costs
-
0
0
0
Payment of finance lease obligations
1,684
810
2,165
2,029
Proceeds from issuance of common stock in initial public offering, net of underwriting discounts
-
0
0
392,862
Deferred initial public offering costs
0
0
1,852
2,811
Issuance of common stock
-
1,500
-
-
Exercise of stock options
1,827
-
-
-
Cash provided by (used for) financing activities
-3,150
-49,205
-207,309
-969
Effect of exchange rate changes on cash
956
600
713
-675
Net change in cash and cash equivalents
-59,882
-260,873
51,205
215,856
Cash and cash equivalents, at the beginning of the period
253,519
463,187
463,187
389,830
Cash and cash equivalents, at the end of the period
193,637
253,519
514,392
463,187
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Total adjusted ebitda
$207,046K
(8.17%↑ Y/Y)
Net income (loss)
$57,860K
(11425.90%↑ Y/Y)
Amortization of intangibles
$53,500K
(-6.74%↓ Y/Y)
Other current
liabilities
$42,342K
(246.13%↑ Y/Y)
Amortization of capitalized
contract costs-Royalty
$38,039K
(9.72%↑ Y/Y)
Depreciation (including
amortization of technology...
$16,348K
(-4.88%↓ Y/Y)
Amortization of product
development costs
$13,628K
(2.45%↑ Y/Y)
Inventories
-$7,864K
(25.42%↑ Y/Y)
Amortization of capitalized
contract...
$7,655K
(2.96%↑ Y/Y)
Inventory obsolescence
$3,958K
(13.54%↑ Y/Y)
Stock-based compensation
$3,884K
Amortization of debt discount
$3,166K
(-5.55%↓ Y/Y)
Amortization of deferred
financing costs
$1,222K
(-2.47%↓ Y/Y)
Deferred income taxes
$255K
(-70.49%↓ Y/Y)
Canceled cashflow
$149,186K
Effect of exchange rate
changes on cash
$956K
(57.24%↑ Y/Y)
Cash provided by
(used for) operating...
$601K
(100.62%↑ Y/Y)
Canceled cashflow
$249,120K
Depreciation, amortization
and product...
$83,476K
(-4.98%↓ Y/Y)
Interest expense
(income), net
-$45,770K
(22.13%↑ Y/Y)
Income tax benefit
(provision)
$10,652K
(-71.17%↓ Y/Y)
Stock-based compensation
$3,884K
Restructuring and cost savings
implementation charges
$3,746K
(20.61%↑ Y/Y)
Other
$1,658K
(1.66%↑ Y/Y)
Net change in cash
and cash...
-$59,882K
(57.98%↑ Y/Y)
Canceled cashflow
$1,557K
Payment of a&e term loan
facility
-$388,990K
(-11916.22%↓ Y/Y)
Exercise of stock options
$1,827K
Deferred revenue
-$149,389K
(-442.19%↓ Y/Y)
Accounts payable and
accrued expenses
-$63,566K
(30.58%↑ Y/Y)
Accounts receivable
$18,041K
(-82.87%↓ Y/Y)
Prepaid and other
current assets
$16,360K
(-41.95%↓ Y/Y)
Credit losses on
accounts receivable
-$1,251K
(45.28%↑ Y/Y)
Other changes in
operating assets and...
$513K
(-87.05%↓ Y/Y)
Cash provided by
(used for) investing...
-$58,289K
(-49.19%↓ Y/Y)
Cash provided by
(used for) financing...
-$3,150K
(57.34%↑ Y/Y)
Canceled cashflow
$390,817K
Product development
expenditures
$34,360K
(50.78%↑ Y/Y)
Capital expenditures
$23,929K
(46.96%↑ Y/Y)
something is missing
-$392,283K
Payment of finance lease
obligations
$1,684K
(-1.98%↓ Y/Y)
Buy us a coffee
McGraw Hill, Inc. (MH)
McGraw Hill, Inc. (MH)